Dystrophic Epidermolysis Bullosa: Pathogenesis and Clinical Features
Leena Bruckner-Tuderman
20100001
2010 Jan 1
Dermatol Clin
Dystrophic Epidermolysis Bullosa: Pathogenesis and Clinical Features
Dermatol Clin. 2010 Jan;28(1):107-114, Leena Bruckner-Tuderman
Abstract
Abstract
Dystrophic epidermolysis bullosa (DEB) is relatively well understood. Potential therapies are in development. This article describes the pathogenesis and clinical features of DEB. It also describes therapeutic options and the future of molecular therapies.
